Title:
APPLICATION OF PYRIDO[1,2-A]PYRIMIDONE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2023/046182
Kind Code:
A1
Abstract:
Provided is an application of a pyrido[1,2-a]pyrimidone compound, and specifically involved is an application of a substance X in preparation of a drug. The substance X is a compound represented by formula I, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof; and the drug is used for treating pancreatic neuroendocrine tumors. The compound can inhibit the growth of pancreatic neuroendocrine tumors and improve the blood glucose level.
Inventors:
LI YONGGUO (CN)
WEI WEI (CN)
YE WEI (CN)
WEI WEI (CN)
YE WEI (CN)
Application Number:
PCT/CN2022/121443
Publication Date:
March 30, 2023
Filing Date:
September 26, 2022
Export Citation:
Assignee:
GUANGZHOU JOYO PHARMATECH CO LTD (CN)
SHANGHAI JIA TAN PHARMATECH CO LTD (CN)
SHANGHAI JIA TAN PHARMATECH CO LTD (CN)
International Classes:
C07D471/04; A61K31/519; A61P35/00; C07D519/00
Domestic Patent References:
| WO2008144463A1 | 2008-11-27 |
Foreign References:
| CN105461712A | 2016-04-06 | |||
| CN105461711A | 2016-04-06 |
Other References:
HAN XU, WEN-HUI LOU: "Advances in Ｒesearch on Genotyping and the Molecular Mechanism of Pancreatic Neuroendocrine Neoplasias", MEDICAL JOURNAL OF PEKING UNION MEDICAL COLLEGE HOSPITAL, vol. 11, no. 4, 31 July 2020 (2020-07-31), pages 377 - 382, XP093054273, ISSN: 1674-9081, DOI: 10.3969/j.issn.1674-9081.2020.04.004
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: SOLID ELECTROLYTE AND LITHIUM ION BATTERY COMPRISING SAME
Next Patent: PROJECTION APPARATUS
Next Patent: PROJECTION APPARATUS